Back to Rhode Island

S2112 • 2026

AN ACT RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES (Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.)

AN ACT RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES (Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.)

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Lauria, DiMario, Murray, Valverde, Kallman, Ujifusa, Pearson, Zurier, Urso, Euer
Last action
2026-04-14
Official status
Committee recommended measure be held for further study
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2026-04-14 Committee

    Committee recommended measure be held for further study

  2. 2026-04-10 Rhode Island General Assembly

    Scheduled for hearing and/or consideration (04/14/2026)

  3. 2026-01-16 Rhode Island General Assembly

    Introduced, referred to Senate Health and Human Services

Official Summary Text

AN ACT RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES (Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.)

Current Bill Text

Read the full stored bill text
S2112

2026 -- S 2112
========
LC003653
========

STATE OF RHODE ISLAND
IN GENERAL ASSEMBLY
JANUARY SESSION, A.D. 2026
____________
A N A C T
RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES

Introduced By:
Senators Lauria, DiMario, Murray, Valverde, Kallman, Ujifusa, Pearson,
Zurier, Urso, and Euer

Date Introduced:
January 16, 2026

Referred To:
Senate Health & Human Services
It is enacted by the General Assembly as follows:
1
SECTION 1. Findings of fact
2
The Rhode Island general assembly recognizes that glucagon auto-injectors are life-saving
3
medications, that must be administered quickly to be effective. Such administration is often done
4
by persons who are not health care professionals, and is done in an emergency situation.
5
Accordingly, it is in the best interests of the people of the state to promote the widespread
6
availability of glucagon, that does not require reconstitution. Hypoglycemia, or low blood glucose,
7
is a barrier to diabetes control, leads to worse clinical outcomes, stress, increased cost of care and
8
polypharmacy. For unconscious patients, and those unable to ingest oral glucose, glucagon in the
9
ambulatory setting is indicated, but often underutilized, due to excessive cost.
10
SECTION 2. Chapter 27-18 of the General Laws entitled "Accident and Sickness Insurance
11
Policies" is hereby amended by adding thereto the following section:
12

27-18-96. Glucagon hypoglycemia medications.

13

Every individual or group health insurance contract, plan, or policy that provides
14
prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state
15
on or after January 1, 2027, shall provide coverage for at least one type of glucagon auto-injector,
16
nasal spray or formulation not requiring reconstitution. There shall be no copayment required and
17
no deductible shall need to be met, to obtain two (2) glucagon auto-injectors, nasal spray or non-
18
reconstituted formulation covered by the contract, plan, or policy, every twelve (12) month plan
19
year. A deductible may be applied to health plans that are paired with federally qualified health

1
savings account pursuant to 26 U.S.C § 223. Nothing in this section would prohibit a health plan
2
from implementing this benefit prior to January 1, 2027.
3
SECTION 3. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service
4
Corporations" is hereby amended by adding thereto the following section:
5

27-19-88. Glucagon hypoglycemia medications.

6

Every individual or group health insurance contract, plan, or policy that provides
7
prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state
8
on or after January 1, 2027, shall provide coverage for at least one type of glucagon auto-injector,
9
nasal spray or formulation not requiring reconstitution. There shall be no copayment required and
10
no deductible shall need to be met, to obtain two (2) glucagon auto-injectors, nasal spray or non-
11
reconstituted formulation covered by the contract, plan, or policy, every twelve (12) month plan
12
year. A deductible may be applied to health plans that are paired with federally qualified health
13
savings account pursuant to 26 U.S.C § 223. Nothing in this section would prohibit a health plan
14
from implementing this benefit prior to January 1, 2027.
15
SECTION 4. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service
16
Corporations" is hereby amended by adding thereto the following section:
17

27-20-84. Glucagon hypoglycemia medications.

18

Every individual or group health insurance contract, plan, or policy that provides
19
prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state
20
on or after January 1, 2027, shall provide coverage for at least one type of glucagon auto-injector,
21
nasal spray or formulation not requiring reconstitution. There shall be no copayment required and
22
no deductible shall need to be met, to obtain two (2) glucagon auto-injectors, nasal spray or non-
23
reconstituted formulation covered by the contract, plan, or policy, every twelve (12) month plan
24
year. A deductible may be applied to health plans that are paired with federally qualified health
25
savings account pursuant to 26 U.S.C § 223. Nothing in this section would prohibit a health plan
26
from implementing this benefit prior to January 1, 2027.
27
SECTION 5. Chapter 27-41 of the General Laws entitled "Health Maintenance
28
Organizations" is hereby amended by adding thereto the following section:
29

27-41-101. Glucagon hypoglycemia medications.

30

Every individual or group health insurance contract, plan, or policy that provides
31
prescription coverage and that is delivered, issued for delivery, prescribed, or renewed in this state
32
on or after January 1, 2027, shall provide coverage for at least one type of glucagon auto-injector,
33
nasal spray or formulation not requiring reconstitution. There shall be no copayment required and
34
no deductible shall need to be met, to obtain two (2) glucagon auto-injectors, nasal spray or non-

LC003653 - Page 2 of 4
1
reconstituted formulation covered by the contract, plan, or policy, every twelve (12) month plan
2
year. A deductible may be applied to health plans that are paired with federally qualified health
3
savings account pursuant to 26 U.S.C § 223. Nothing in this section would prohibit a health plan
4
from implementing this benefit prior to January 1, 2027.
5
SECTION 6. This act shall take effect upon passage.
========
LC003653
========

LC003653 - Page 3 of 4
EXPLANATION
BY THE LEGISLATIVE COUNCIL
OF
A N A C T
RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES
***
1
This act would require, commencing January 1, 2027, group health plans and health
2
insurance issuers that provide prescription benefits to cover at least one type of glucagon auto-
3
injector, nasal spray, or formulation which does not require reconstitution to treat hypoglycemia
4
with two (2) glucagon auto-injectors every plan year. No copayment or deductible would be
5
required to obtain prescribed glucagon medications.
6
This act would take effect upon passage.
========
LC003653
========

LC003653 - Page 4 of 4